Beauty M&A is entering a new era defined by precision, science and strategic focus.
Beauty M&A is entering a new era defined by precision, science and strategic focus.
Why the Puig–Estée Lauder non‑merger signals a new era of disciplined dealmaking.
Beauty M&A is entering a new era defined by precision, science and strategic focus. FRP Corporate Finance Partner Victoria Kisseleva explores how the market is moving toward sharper strategy, stronger science and tighter portfolio clarity as brands and buyers prioritise fit over size.
A concise look at the signals, the strategy, and the disciplined new chapter ahead for beauty dealmaking.
Across the board, three forces are driving dealmaking: clinical credibility, loyalty economics, and scalable omnichannel models. Brands that can prove efficacy, repeat behaviour, and global potential will define the next wave as the market continues to recalibrate.